The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
Carlos Alves, Ana Penedones, Diogo Mendes, Francisco Batel Marques
Topics & Concepts
MedicineAtopic dermatitisAdverse effectDiscontinuationTofacitinibPlaceboInternal medicineJanus kinase inhibitorDermatologyJanus kinaseAlternative medicineRheumatoid arthritisPathologyCytokineDermatology and Skin DiseasesUrticaria and Related ConditionsAllergic Rhinitis and Sensitization